ARTICLE | Clinical News
Micardis telmisartan: Phase IV data
April 7, 2008 7:00 AM UTC
In the double-blind, international Phase IV ONTARGET trial in 25,620 high-risk cardiovascular patients, the 56-month rate of cardiovascular death, myocardial infarction, stroke and hospitalization for...